AI Insight: Ingersoll Rand’s current price slightly exceeds the high-confidence fair value estimate ($70.95), indicating a modest overvaluation with 83.3% downside risk per Monte Carlo analysis. Key valuation metrics, notably EV/EBITDA and analyst targets, suggest potential upside, contrasting lower DCF and P/E valuations. Financial health signals fair liquidity but weak growth and profitability, implying elevated investment risk amid valuation uncertainty.